Lode Jan Swinnen, M.B.Ch.B., M.D., M.S.

Clinical Trial Keywords

AIDS Associated Maliganancies, Lymphomas

Selected Publications

Abrey, L.E.; Childs, B.H.; Paleologos, N.; Kaminer, L.; Rosenfeld, S.; Salzman, D.; Finlay, J.L.; Gardner, S.; Peterson, K.; Hu, W.; Swinnen, L.; Bayer, R.; Forsyth, P.; Stewart, D.; Smith, A.M.; Macdonald, D.R.; Weaver, S.; Ramsay, D.A.; Nimer, S.D.; DeAngelis, L.M.; Cairncross, J.G. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro-oncology. 2006 Apr;8(2):183-188.

Djokic, M.; Le Beau, M.M.; Swinnen, L.J.; Smith, S.M.; Rubin, C.M.; Anastasi, J.; Carlson, K.M. Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities. Genes Chromosomes Cancer. 2006 Mar;45(3):313-318.

Swinnen, L.J. Immune-cell treatment of Epstein-Barr-virus-associated lymphoproliferative disorders. Best Pract Res Clin Haematol. 2006;19(4):839-847.

Swinnen, L.J. Early treatment intensification for aggressive non-Hodgkin''s lymphoma. Curr Opin Oncol. 2006 Sep;18(5):415-416.

Bolanos-Meade, J.; Garrett-Mayer, E.; Luznik, L.; Anders, V.; Webb, J.; Fuchs, E.J.; Huff, C.A.; Matsui, W.; Borrello, I.M.; Brodsky, R.; Kasamon, Y.L.; Swinnen, L.J.; Flinn, I.W.; Ambinder, R.F.; Jones, R.J.; Hess, A.D.; Vogelsang, G.B. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant. 2007 Oct;13(10):1185-1191.

Swinnen, L.J.; LeBlanc, M.; Grogan, T.M.; Gordon, L.I.; Stiff, P.J.; Miller, A.M.; Kasamon, Y.; Miller, T.P.; Fisher, R.I. Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. Transplantation. 2008 Jul 27;86(2):215-222.

Swinnen, L.J.; Rankin, C.; Carraway, H.; Albain, K.S.; Townsend, J.J.; Budd, G.T.; Kish, J.A.; Rivkin, S.E.; Blumenthal, D.T. A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149). J Neurooncol. 2008 Feb;86(3):353-358.

Bolanos-Meade, J.; Luznik, L.; Muth, M.; Matsui, W.H.; Huff, C.A.; Smith, B.D.; Levy, M.Y.; Kasamon, Y.L.; Swinnen, L.J.; Powell, J.D.; Brodsky, R.A.; Ambinder, R.F.; Jones, R.J.; Fuchs, E.J. Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. Bone Marrow Transplant. 2009 Mar;43(6):477-480.

Kasamon, Y.L.; Luznik, L.; Leffell, M.S.; Kowalski, J.; Tsai, H.L.; Bolanos-Meade, J.; Morris, L.E.; Crilley, P.A.; O''Donnell, P.V.; Rossiter, N.; Huff, C.A.; Brodsky, R.A.; Matsui, W.H.; Swinnen, L.J.; Borrello, I.; Powell, J.D.; Ambinder, R.F.; Jones, R.J.; Fuchs, E.J. Nonmyeloablative HLA-Haploidentical BMT with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome. Biol Blood Marrow Transplant. 2009 Nov 16.

Kasamon, Y.L.; Wahl, R.L.; Ziessman, H.A.; Blackford, A.L.; Goodman, S.N.; Fidyk, C.A.; Rogers, K.M.; Bolanos-Meade, J.; Borowitz, M.J.; Ambinder, R.F.; Jones, R.J.; Swinnen, L.J. Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning. Biol Blood Marrow Transplant. 2009 Feb;15(2):242-248.

Swinnen, L.J. Primary central nervous system lymphoma: recent progress, many remaining questions. Curr Opin Oncol. 2009 Sep;21(5):393-396.

Kasamon, Y.L.; Luznik, L.; Leffell, M.S.; Kowalski, J.; Tsai, H.L.; Bolanos-Meade, J.; Morris, L.E.; Crilley, P.A.; O''Donnell, P.V.; Rossiter, N.; Huff, C.A.; Brodsky, R.A.; Matsui, W.H.; Swinnen, L.J.; Borrello, I.; Powell, J.D.; Ambinder, R.F.; Jones, R.J.; Fuchs, E.J. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant. 2010 Apr;16(4):482-489.